Med spa weight-loss injections

A med spa offering prescription medicine is operating under someone's medical licence. In most states that means a physician medical director, with nurse practitioners or physician assistants doing the assessing and prescribing under an arrangement whose independence varies enormously by state.

In some states a nurse practitioner may assess and prescribe independently. In others a collaborative or supervisory agreement with a physician is required. In a few, the ownership structure of the business itself is constrained by corporate-practice-of-medicine rules.

None of that is visible from the waiting room, which is why asking is reasonable rather than rude.

• Who is the medical director, and are they physically present or reachable when I am being assessed?
• Who will assess me, what licence do they hold, and what does that licence permit independently in this state?
• Is laboratory work ordered before prescribing, and by whom?
• Is the medication the FDA-approved product or a compounded preparation — and if compounded, which pharmacy prepares it?
• What is the process if I have a side effect at the weekend? Who do I actually reach?
• What is the total cost including follow-up, and what happens to the price after any introductory offer?

The after-hours question is the most revealing of the six. A practice built as a clinical service has a clear answer to it. A practice built as a storefront points you at an inbox.

Med spas are disproportionately likely to supply compounded preparations rather than branded product, because the economics of a cash-pay aesthetics business favour it. That makes the compounding questions more pressing in this setting than in a physician's office.

The status of compounded GLP-1 preparations is unsettled and we treat it as under review rather than stating it as settled fact. FDA's guidance to compounders sets out an "essentially a copy" test: a compounded product with the same active ingredient as a commercially available drug, in the same or an easily substitutable strength and by the same route, is generally treated as a copy unless a prescriber documents a significant difference for a specific patient. What that means for any particular preparation is a question for the pharmacy and the prescriber, not something a directory can answer for you.

FDA has flagged combination preparations specifically — semaglutide compounded with vitamin B12 is the example the agency itself gives of something that may be treated as essentially a copy of a commercially available product. If you are offered a combination, that is worth asking about directly.

A med spa with a present medical director, real laboratory work, named pharmacy supply and a reachable clinician is a legitimate route to this medicine. A med spa without those things is selling you an injection and calling it care.

FDA publishes a list of telehealth warning signs for consumers, and it is worth reading before you hand over a card. Among them: a company claiming a compounded drug is the same as an FDA-approved one, prices that look too good to be true, medicine arriving that looks different from what was pictured, no screening or prescription by a licensed doctor, no licensed doctor reachable after the medicine arrives, and labels with spelling errors, wrong pharmacy addresses, or a pharmacy name that does not check out.

• FDA — FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize — retrieved 2026-08-06
• FDA — FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — retrieved 2026-08-06